<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50230">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01845129</url>
  </required_header>
  <id_info>
    <org_study_id>RAPH_01EO0801</org_study_id>
    <nct_id>NCT01845129</nct_id>
  </id_info>
  <brief_title>Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia</brief_title>
  <acronym>StimRAph</acronym>
  <official_title>Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study assesses whether language functions in patients with residual post-stroke
      aphasia can be improved by transcranial direct current stimulation administered to the
      primary motor cortex in the language dominant (left) hemisphere.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will participate in two tDCS sessions (atDCS; sham) in a cross-over within subjects
      design. tDCS or placebo will be administered during simulatneous fMRI to assess neural
      signatures of the stimulation. Order of stimulation will be counterbalanced between subjects
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Response latency during picture naming task (max. 80)</measure>
    <time_frame>Change in response latency between assessment 1 (week 1) and assessment 2 (week 2), assessments 1 and 2 are seperated by one week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subjects are assessed in a cross-over design. The primary outcome measure will be assessed twice in each subject, either during placebo (&quot;sham) stimulation or active (anodal) stimulation with transcranial direct current stimulation. Order of stimulation will be counterbalanced across the group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in neural activity measured by functional magnetic resonance imaging</measure>
    <time_frame>Change in fMRI activity between Assessment 1 (week 1) and Assessment 2 (week 2), assessments 1 and 2 are seperated by one week</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Residual Aphasia</condition>
  <arm_group>
    <arm_group_label>anodal tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>atDCS will be administered for 20 minutes with 1 milliampere (1 mA) to the left primary hand motor cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham tDCS will be administered to the left primary hand motor cortex</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>atDCS</intervention_name>
    <description>atDCS will be delivered with a constant current of 1 mA during simultaneous resting-state (RS) and task-related (picture naming) functional magnetic resonance imaging (fMRI). The current will be turned on prior to the RS-fMRI scan and continues for 20 minutes.</description>
    <arm_group_label>anodal tDCS</arm_group_label>
    <arm_group_label>sham tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham tDCS</intervention_name>
    <description>During sham the current will be increeased and decreased in a ramp-like fashion (10 sec)</description>
    <arm_group_label>anodal tDCS</arm_group_label>
    <arm_group_label>sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  right handedness

          -  German native speaker

          -  cerebrovascular stroke in left hemisphere (&gt;6 months)

          -  mild aphasia (according to Aachen Aphasia Test Battery Classification, Huber et al.,
             1983)

          -  residual anomia in naming test (&gt;75 correct responses)

        Exclusion Criteria:

          -  other current or previous neurological or psychiatric diseases

          -  alcohol or drug abuse

          -  MRI contraindication (e.g. magnetic metal, pacemaker, claustrophobia)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus Meinzer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite, University Medicine, Neurology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Agnes Flöel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite, University Medicine, Neurology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Darkow, MSc</last_name>
    <phone>+49 30 450 560</phone>
    <phone_ext>395</phone_ext>
    <email>robert.darkow@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charite, University Medicine, Dept. of Neurology</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Darkow, MSc</last_name>
      <phone>+49 30 450 560</phone>
      <phone_ext>395</phone_ext>
      <email>robert.darkow@charite.de</email>
    </contact>
    <investigator>
      <last_name>Marcus Meinzer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agnes Flöel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 30, 2013</lastchanged_date>
  <firstreceived_date>April 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Marcus Meinzer</investigator_full_name>
    <investigator_title>Creutzfeldt Fellow</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aphasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
